February 4, 2017 - Innovation AveNEW is a traditional highlight of the annual SLAS Conference and Exhibition. Through this program, SLAS provides start-up companies with tremendous exposure and prestige by granting complimentary exhibit space and in-kind support that enables the company's participation at the SLAS Annual Conference & Exhibition.
February 28, 2017 - One of the many highlights of the evening is to hear the success stories of these finalists and learn about their approach to growth. Many are also making an impact on the community as well through their work.
June 22, 2017 - StemoniX® is joining the ranks of Google & Labcyte as winners of one of the technology industry's most prestigious honors. The company, with offices in the Twin Cities and San Diego, was awarded a 2017 Red Herring Top 100 North America award for revolutionizing the way medicine is discovered. StemoniX makes it possible to test medication on humans without that medicine ever entering their bodies.
Pairnomix, StemoniX Develop Epilepsy Model in Search for New Anti-seizure Drugs
July 24, 2017 - Pairnomix has joined efforts with StemoniX to develop a lab-based model of epileptic seizures using so-called induced pluripotent stem cells (iPSCs).
The model, which researchers refer to as a “seizure-in-a-dish” model system, will allow scientists to study seizures at a network level. In this way, they can use the model to screen for anti-epileptic drugs in a fast and easy manner.
October 9, 2017 - In our recent Minnesota Life Science Companies to Watch series, here and here we featured a number of up and coming companies including StemoniX. In this series, we go deeper in analyzing individual companies in our own backyard and discuss how they grew their startup. In conjunction with the 13th annual MN Cup awards, we highlight last year’s grand prize winner, StemoniX.